Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings

Magnetic Resonance Imaging

Volumn 21, Issue 1, 2003, Pages 77-80

  Alkana, Alpay ^a   Kutlu, Ramazan ^a   Yakinci, Cengiz ^b   Sigirci, Ahmet ^a   Aslan, Mehmet ^b   Sarac, Kaya ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

MR spectroscopy; Rhizomelic chondrodysplasia punctata

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; GLYCINE; LIPID; PLASMALOGEN;

ARTICLE; BRAIN METABOLISM; CASE REPORT; CHONDRODYSPLASIA PUNCTATA; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; EQUIPMENT; GENETIC DISORDER; HUMAN; INFANT; LIPOGENESIS; MALE; METABOLITE; MYELINATION; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ASPARTIC ACID; CHOLINE; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC; CREATINE; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYELIN SHEATH;

EID: 0037219940     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(02)00625-2     Document Type: Article

References (17)

1. Powers JM, Moser HW. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions and pathogenesis. Brain Pathol 1998;8:101-20.
2. Ofman R, Hettema EH, Hogenhout EM, Caruso U, Muijsers AO, Wanders RJA. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA, and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum Mol Genet 1998;7(5):847-53.
3. Hebestreit H, Wanders RJA, Schutgens RBH, Espeel M, Kercaert I, Roels F, Schmausser B, Schrod L, Marx A. Isolated dihydroxyacetonephosphate-acyl-transferase deficiency in rhizomelic chondrodysplasia punctata: clinical presentation, metabolic and histological findings. Eur J Pediatr 1996;155:1035-9.
4. Viola A, Gouny SC, Ranjeva JP, Chabrol B, Raybaud C, Vintila F, Cozzone PJ. MR imaging, and MR spectroscopy in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 2002;23:480-3.
5. Williams DW, Elster AD, Cox TD. Cranial MR imaging in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 1991;12:363-5.
6. Sztriha L, Al-Gazali LI, Wanders RJ, Ofman R, Nork M, Lestringant GG. Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency). Dev Med Child Neurol 2000;42:492-5.
7. Van der Knaap MS, Valk J. The MR spectrum of peroxisomal disorder. Neuroradiology 1991;33:30-7.
8. Biermann J, Just WW, Wanders RA, van den Bosch H. Alkyldihydroxyacetone phosphate synthase, and dihydroxyacetone phosphate acyltransferase form a protein complex in peroxisomes. Eur J. Biochem 1999;261:492-9.
9. de Vet ECJM, Ijlst L, Oostheim W, Dekker C, Moser HW, van den Bosch H, Wanders JA. Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. J Lipid Res 1998; 40(11):1998-2003.
10. Braverman N, Steel G, Obie C, et al. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 1997;15:377-80.
11. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15.
12. Holshouser BA, Ashwall S, Luh GY, Shu S, Kahlon S, Auld L, Tomasi LG, Perkin RM, Hinshaw DB. Proton MR spectroscopy after acute central nervous system injury: Outcome prediction in neonates, infants, and children. Radiology 1997;202:487-96.
13. Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: Assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2001;22:128-35.
14. Bruhn H, Kruse B, Korenke GC, et al. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 1992;16:335-44.
15. Pouwels PJ, Kruse B, Korenke GC, Mao X, Hanefeld FA, Frahm J. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254-64.
16. Confort-Gouny S, Vion-Dury J, Chabrol B, Nicoli F, Cozzone PJ. Localized proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 1995;37:568-75.
17. Filippi CG, Ulug AM, Deck MD, Zimmerman RD, Heier LA. Developmental delay in children: Assessment with Proton MR Spectroscopy. AJNR Am J Neuroradiol 2002;23:882-8.